Introduction
A drug substance must often be formulated into a suitable pharmaceutical preparation before it can be administered effectively. The dosage form determines how the active ingredient is presented, delivered and released. Formulation science considers drug stability, solubility, patient acceptability, manufacturing requirements and the intended route of administration. The same active ingredient may be available in multiple dosage forms, each with different characteristics.
Key definitions
| Term | Definition | Examples | Explanation |
|---|---|---|---|
Dosage form | The physical form in which a medicine is prepared for administration. |
| |
Pharmaceutical preparation | A formulated medicinal product containing one or more active ingredients and, where appropriate, excipients. | It is prepared to provide suitable quality, stability, delivery and performance. | |
Formulation | The design and composition of a pharmaceutical product, including the selection and proportions of its ingredients and the processes used to manufacture it. | ||
Immediate-release preparation | A formulation designed to release its active ingredient without intentionally delaying or extending release beyond the characteristics of the conventional dosage form. | ||
Modified-release preparation | A formulation designed to alter the rate, timing or location of drug release compared with a conventional immediate-release product. |
Components of pharmaceutical preparations
| Component | Abbreviation | Function |
|---|---|---|
Active pharmaceutical ingredient | API | Provides the intended pharmacological activity or other direct therapeutic effect. |
Diluent or filler | Provides suitable bulk and physical properties in formulations where additional volume is required. | |
Binder | Helps particles adhere during the manufacture of certain solid dosage forms. | |
Disintegrant | Supports the breakup of a tablet into smaller particles after administration. | |
Lubricant | Reduces friction during manufacturing processes such as tablet compression. | |
Preservative | Helps control microbial contamination in suitable formulations. | |
Antioxidant | Helps reduce oxidative degradation of susceptible ingredients. | |
Stabilizer | Helps maintain formulation properties during storage and use. | |
Solvent or vehicle | Provides a liquid medium in which ingredients may be dissolved, suspended or dispersed. | |
Coating material | May protect the dosage form, modify release or improve acceptability. |
Major dosage form categories
Category
Solid dosage forms
Description
Preparations that have a solid physical structure.
Types
Type Description Characteristics Examples Types Tablets
Solid dosage units generally produced by compression or other suitable manufacturing processes.
Contain a measured quantity of active ingredient.
May include excipients for manufacturing and performance.
Can be coated or uncoated.
May be designed for immediate or modified release.
Conventional tablets
Film-coated tablets
Enteric-coated tablets
Chewable tablets
Sublingual tablets
Capsules
Dosage forms in which active ingredients are enclosed in a suitable shell.
May contain powders, granules, liquids or other suitable preparations.
Can help mask unpleasant taste.
Shell composition and formulation influence performance.
Hard capsules
Soft capsules
Powders and granules
Solid preparations consisting of dry particles or aggregates of particles.
May be intended for direct administration or preparation before use.
Can be packaged as individual doses or multidose products.
Require appropriate control of particle properties and stability.
Lozenges
Solid preparations designed to dissolve or disintegrate slowly in the mouth.
May provide local effects in the oral cavity or throat.
Release characteristics influence contact time.
Category
Liquid dosage forms
Description
Preparations in which active ingredients are dissolved, suspended or dispersed in a liquid vehicle.
Types
Type Description Characteristics Types Solutions
Homogeneous liquid preparations in which one or more substances are dissolved in a suitable solvent or vehicle.
The dissolved substance is distributed throughout the liquid phase.
May provide uniformity when correctly formulated and handled.
Stability depends on chemical and physical properties.
Suspensions
Preparations containing solid particles dispersed in a liquid medium.
Particles may settle during storage.
Appropriate formulation and labeling are important.
Some products require shaking before administration.
Emulsions
Preparations containing two immiscible liquid phases, with one dispersed as droplets within the other.
Require suitable emulsifying systems.
Physical stability is an important formulation consideration.
Oil-in-water
Water-in-oil
Syrups
Concentrated aqueous preparations, often containing sweetening agents and suitable medicinal ingredients.
Can improve acceptability for some oral medicines.
Sugar-free formulations may be available.
Microbial and chemical stability must be considered.
Elixirs
Clear, sweetened hydroalcoholic liquid preparations used in certain pharmaceutical formulations.
Category
Semisolid dosage forms
Description
Preparations with a consistency between solid and liquid, commonly intended for application to skin or mucosal surfaces.
Types
Type Description Ointments
Semisolid preparations that often have an oily or greasy base.
Creams
Semisolid emulsions containing aqueous and oily phases.
Gels
Semisolid systems in which a liquid phase is structured by a gelling agent.
Pastes
Semisolid preparations containing a relatively high proportion of finely dispersed solid material.
Formulation considerations
Drug solubility and stability
Skin or mucosal compatibility
Release from the vehicle
Spreadability and patient acceptability
Microbial quality where relevant
Category
Parenteral preparations
Description
Sterile pharmaceutical preparations intended for administration by injection or infusion.
Types
Solutions for injection
Suspensions for injection
Emulsions for injection
Powders for reconstitution
Concentrates for dilution
Infusion preparations
Quality requirements
Sterility
Appropriate particulate control
Suitable formulation compatibility
Appropriate endotoxin or pyrogen control where required
Correct packaging and labeling
Important note
Parenteral products require specialized quality controls because they bypass some of the body's normal protective barriers.
Category
Inhalational dosage forms
Description
Preparations designed to deliver medicines into the respiratory tract.
Types
Pressurized metered-dose inhalers
Dry-powder inhalers
Nebulizer solutions
Formulation considerations
Particle or droplet characteristics
Device compatibility
Dose consistency
Stability
Respiratory deposition
Category
Transdermal dosage forms
Description
Preparations designed to deliver an active ingredient through the skin into systemic circulation.
Examples
Transdermal patches
Characteristics
May provide sustained drug delivery.
Avoid direct passage through the gastrointestinal tract.
Require suitable drug properties and formulation design.
Are not equivalent to ordinary topical preparations.
Category
Ophthalmic and otic preparations
Description
Specialized preparations intended for administration to the eyes or ears.
Examples
Eye drops
Ophthalmic ointments
Ear drops
Quality considerations
Appropriate formulation compatibility
Microbial quality
Packaging suitability
Stability
Appropriate labeling
Category
Rectal and vaginal preparations
Description
Dosage forms intended for administration through the rectal or vaginal route.
Examples
Suppositories
Pessaries
Rectal creams
Vaginal tablets
Characteristics
May produce local or systemic effects depending on the formulation.
Require suitable physical and chemical properties.
Release and absorption depend on the dosage form and biological environment.
Modified release systems
Definition
Modified-release formulations are designed to alter the timing, location or rate at which an active ingredient becomes available.
Major types
| Type | Description |
|---|---|
Extended-release | Designed to release the active ingredient over a longer period than a conventional immediate-release preparation. |
Delayed-release | Designed to postpone release until a particular condition or location is reached. |
Enteric-coated | Uses a coating designed to resist disintegration in the acidic stomach environment and permit release under suitable intestinal conditions. |
Controlled-release | Designed to regulate drug release according to defined formulation characteristics. |
Important warning
Modified-release products are not automatically interchangeable with immediate-release products. Altering, crushing or opening a dosage form can change its intended performance and should only be considered when supported by authoritative product instructions.
Factors influencing dosage form selection
| Factor | Explanation |
|---|---|
Drug properties | Solubility, stability, molecular size and other physicochemical properties influence formulation options. |
Intended route | The route of administration determines important requirements for the dosage form. |
Desired onset and duration | Some clinical situations require rapid availability, while others may benefit from sustained delivery. |
Patient characteristics | Age, swallowing ability, physical limitations and preferences may influence formulation suitability. |
Site of action | A local effect may require a topical or localized preparation, whereas systemic treatment requires suitable absorption or delivery. |
Stability | Some substances require specialized formulations to protect them from degradation. |
Manufacturing feasibility | The formulation must be capable of consistent production under appropriate quality controls. |
Quality control and evaluation
| Test | Purpose |
|---|---|
Identity testing | Confirms that the product contains the intended active ingredient. |
Assay | Measures the amount or concentration of the active ingredient. |
Content uniformity | Evaluates whether individual dosage units contain suitably consistent amounts of active ingredient. |
Dissolution testing | Investigates how the active ingredient is released into a specified test medium under defined conditions. |
Disintegration testing | Evaluates the breakup of certain solid dosage forms under specified test conditions. |
Stability testing | Investigates changes in product quality under defined storage conditions. |
Microbiological testing | Evaluates microbial quality and, where required, sterility. |
Packaging evaluation | Assesses whether the container and closure protect the product appropriately. |
Common misconceptions
| Misconception | Correction |
|---|---|
Dosage form and route of administration are identical. | Dosage form describes the physical preparation, while route describes how it enters or is applied to the body. |
All tablets release their active ingredient in the same way. | Tablets may have immediate-release, delayed-release or other modified-release properties. |
Creams, ointments and gels are interchangeable. | They differ in composition, physical properties, release characteristics and suitability for particular applications. |
All liquid medicines are solutions. | Some are suspensions or emulsions and have different physical properties. |
A transdermal patch is simply a topical cream in another form. | Transdermal systems are designed for delivery through the skin into systemic circulation, whereas many topical products are intended primarily for local action. |
Practical label interpretation
Important label elements
Medicine name
Active ingredient
Strength or concentration
Dosage form
Route of administration
Batch or lot number
Expiry date
Storage conditions
Manufacturer information
Educational task
Compare the labels of a tablet, an oral suspension and a topical cream. Identify their active ingredients, dosage forms, strengths and intended routes. Explain why their formulations differ.